Reuters |
Exclusive: Top Mylan shareholders seek deal with Teva - sources
Reuters (Reuters) - Some of the top investors at Mylan NV (MYL.O), including Paulson & Co, are encouraging its board of directors to consider a takeover proposal from rival Teva Pharmaceutical Industries Inc (TEVA.TA), according to people familiar with the matter. Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger Teva proposes $40 billion acquisition of competitor Mylan |
No comments:
Post a Comment